Sagan S, Beaujouan J C, Torrens Y, Saffroy M, Chassaing G, Glowinski J, Lavielle S
Laboratoire de Chimie Organique Biologique, URA CNRS 493, Université Pierre et Marie Curie, Paris, France.
Mol Pharmacol. 1997 Jul;52(1):120-7. doi: 10.1124/mol.52.1.120.
Propionyl-[Met(O2)11]substance P(7-11) [ALIE-124 or propionyl-[Met(O2)11]SP(7-11)] has been designed as a septide-like ligand adequate for tritiation and, therefore, adequate for binding studies. In Chinese hamster ovary (CHO) cells expressing human tachykinin neurokinin (NK)-1 receptors, ALIE-124 displaced [3H][Pro9]substance P (SP) from its binding site at micromolar concentrations. However, ALIE-124 stimulated phosphatidylinositol hydrolysis, as previously shown for septide-like peptides. With [3H]ALIE-124 (95 Ci/mmol), we have been able to reveal a high affinity binding site in CHO cells (Kd = 6.6 +/- 1.0 nM), with a low maximal binding capacity. [3H]ALIE-124 specific maximal binding represented only 15-20% of that observed with [3H][Pro9]SP in CHO cells. Septide-like peptides, including septide and NKA, were potent competitors (in the nanomolar range) of [3H]ALIE-124 specific binding site. Interestingly, SP and [Pro9]SP were also potent competitors, with 10-fold greater potency for sites labeled with [3H]ALIE-124 than for sites labeled with [3H][Pro9]SP. The NK-1 antagonist RP 67580 also showed a higher potency for [3H]ALIE-124 than for [3H][Pro9]SP-specific binding sites. NKB and [Lys5,methyl-Leu9,Nle10]NKA(4-10) displaced [3H]ALIE-124 binding but with lower potency, whereas senktide had no affinity. The existence of [3H]ALIE-124 specific binding sites was also demonstrated in rat submandibular gland. In this tissue, [3H]ALIE-124 specific maximal binding was higher, reaching 40-50% of that achieved with [3H][Pro9]SP.
丙酰基-[甲硫氨酸(亚砜)11]P物质(7-11)[ALIE-124或丙酰基-[甲硫氨酸(亚砜)11]P物质(7-11)]被设计为一种类似七肽的配体,适合进行氚标记,因此适合用于结合研究。在中国仓鼠卵巢(CHO)细胞中表达人速激肽神经激肽(NK)-1受体时,ALIE-124在微摩尔浓度下从其结合位点取代了[3H][脯氨酸9]P物质(SP)。然而,正如之前对类似七肽的肽所显示的那样,ALIE-124刺激了磷脂酰肌醇水解。使用[3H]ALIE-124(95 Ci/mmol),我们能够在CHO细胞中揭示一个高亲和力结合位点(Kd = 6.6 +/- 1.0 nM),其最大结合容量较低。[3H]ALIE-124的特异性最大结合仅占CHO细胞中[3H][脯氨酸9]SP所观察到的结合的15 - 20%。包括七肽和神经激肽A(NKA)在内的类似七肽的肽是[3H]ALIE-124特异性结合位点的有效竞争者(在纳摩尔范围内)。有趣的是,SP和[脯氨酸9]SP也是有效竞争者,对用[3H]ALIE-124标记的位点的效力比对用[3H][脯氨酸9]SP标记的位点高10倍。NK-1拮抗剂RP 67580对[3H]ALIE-124的效力也比对[3H][脯氨酸9]SP特异性结合位点的效力高。神经激肽B(NKB)和[赖氨酸5,甲基-亮氨酸9,Nle10]NKA(4-10)取代了[3H]ALIE-124的结合,但效力较低,而速激肽原没有亲和力。在大鼠颌下腺中也证明了[3H]ALIE-124特异性结合位点的存在。在该组织中,[3H]ALIE-124的特异性最大结合较高,达到[3H][脯氨酸9]SP所达到的结合的40 - 50%。